Outcome in six children with mucopolysaccharidosis type IH, hurler syndrome, after haematopoietic stem cell transplantation (HSCT)

Acta Paediatrica, International Journal of Paediatrics

Volumn 97, Issue 8, 2008, Pages 1108-1112

  Malm, Gunilla ^a,b   Gustafsson, Britt ^a   Berglund, Gunilla ^b   Lindström, Maria ^b   Naess, Karin ^a   Borgström, Birgit ^a   Von Döbeln, Ulrika ^b   Ringdén, Olle ^c  

^a Division of Paediatrics ^*  (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Bone marrow transplantation; Developmental outcome; Mucopolysaccharidosis

Indexed keywords

ARTICLE; BONE MALFORMATION; CARPAL TUNNEL SYNDROME; CHILD; CHIMERA; CLINICAL ARTICLE; COGNITION; ECHOCARDIOGRAPHY; ENZYME REPLACEMENT; EYE EXAMINATION; FOLLOW UP; GROWTH RETARDATION; HEARING TEST; HEART VALVE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HIP SURGERY; HUMAN; HURLER SYNDROME; INFANT; LABORATORY TEST; NEUROPHYSIOLOGY; PRESCHOOL CHILD; PRIORITY JOURNAL; RETRANSPLANTATION; SPINE SURGERY; SWEDEN; COGNITIVE DEFECT; EARLY DIAGNOSIS; FEMALE; GENETICS; GENOTYPE; HYPERMETROPIA; MALE; METHODOLOGY; POINT MUTATION; TIME;

CHILD; CHILD, PRESCHOOL; CHIMERISM; COGNITION DISORDERS; EARLY DIAGNOSIS; FEMALE; GENOTYPE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; HYPEROPIA; INFANT; MALE; MUCOPOLYSACCHARIDOSIS I; POINT MUTATION; SWEDEN; TIME FACTORS;

EID: 63849138912     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2008.00811.x     Document Type: Article

References (22)

1. Neufeld EF, Joseph M. The Mucopolysaccharidoses, in the Metabolic & Molecular Bases of Inherited Disease. In: CR Schriver, AL Beaudet, D Valle, WS Sly. editors. New York: McGraw-Hill; 2001. 3421-52.
2. Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, et al. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 2005; 28: 1011-7.
3. Hobbs JR, Hugh-Jones K, Barret AJ, Byrom N, Chambers D, Henry K, et al. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981; 2: 709-12.
4. Peters C, Balthazor M, Shapiro EG, King RJ, Kollman C, Hegland JD, et al. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome. Blood 1996; 87: 4894-902.
5. Boelens JJ. Trends in haematopoietic cell transplantation for inborn errors of metabolism. J Inherit Metab Dis 2006; 29: 413-20.
6. Boelens JJ, Wynn RF, O'Meara A, et al. Outcomes of hematopoietic stem cell transplantation for Hurler's syndrome in Europe: a risk factor analysis for graft failure. Bone Marrow Transplant 2007; 40: 225-33. Epub 2007 May 28.
7. Grewal SS, Wynn R, Abdenur JE, Burton BK, Gharib M, Haase C, et al. Safety and efficacy of enzyme replacement therapy in combination with hematopoietic stem cell transplantation in Hurler syndrome. Genet Med 2005; 7: 143-6.
8. Hirth A, Berg A, Greve G. Successful treatment of severe heart failure in an infant with Hurler syndrome. J Inherit Metab Dis 2007; 30: 820. Epub 2007 Sep 4.
9. Ringden O, Remberger M, Svahn B-M, Barkholt L, Mattson J, Aschan J, et al. Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single centre. Transplantation 2006; 81: 718-25.
10. Remberger M, Svahn B-M, Hentsche P, Löfgren C, Ringden O. Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation. Bone Marrow Transplant 1999; 24: 823-30.
11. Ringden O, Pihlstedt P, Markling L, Aschan J, Baryd I, Ljungman P, et al. Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients. Bone Marrow Transplant 1991; 7: 221-6.
12. Whiteman P. The quantitative determination of glycosaminoglycans in urine with Alcian Blue & GX. Biochem J 1973; 131: 351-7.
13. Hopwood J. A fluoremetric assay using 4-methylumbelliferyl-α-L- iduronide for estimation of α-L-iduronidase activity and the detection of Hurler and Scheies syndromes. Clin Chim Acta 1979; 92: 257-65.
14. Alin-Åkerman B, Nordberg L. Griffiths: "Griffiths, utvecklingsskalor I och II." (Swedish version). Psykologiförlaget AB 1991.
15. Dusing SC, Thorpe D, Rosenberg A, Mercer V, Escolar ML. Gross motor abilities in children with Hurler syndrome. Dev Med Child Neurol 2006; 48: 927-30.
16. Dusing SC, Thorpe DE, Poe MD, Rosenberg AE, Mercer VS, Escolar ML. Gross motor development of children with Hurler syndrome after umbilical cord blood transplantation. Phys Ther 2007; 87: 1433-40. Epub 2007 Sep 4.
17. Fahnehjelm KT, Törnquist AL, Malm G, Winiarski J. Ocular findings in four children with mucopolysaccharidosis I-Hurler. Acta Ophthalmol Scand 2006; 84: 781-5.
18. Staba SL, Esc lar ML, P e M, Kim Y, Martin PL, Szab les P, et al. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004; 350: 1960-9.
19. Renteria VG, Ferrans VJ, Roberts WC. The heart in the Hurler syndrome. Gross, histologic and ultrastructural observations in five necropsy cases. Am J Cardiol 1975; 38: 487-501.
20. Mohan UR, Hay AA, Cleary MA, Wraith JE, Patel RG. Cardiovascular changes in children with mucopolysaccharide disorders. ACTA Pediatrica 2002; 91: 799-804.
21. Braunlin EA, Stauffer NR, Peters CH. Usefulness of bone marrow transplantation in the Hurler syndrome. Am J Cardiol 2003; 92: 882-6.
22. Conway J, Dyack S, Crooks B, Fernandez CV. Mixed donor chimerism and low level iduronidase expression may be adequate for neurodevelopmental protection in Hurler syndrome. J Pediatr 2005; 147: 106-8.